Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1212/nxi.0000000000001008
PubMed Identifier: 34021056
Publication URI: http://europepmc.org/abstract/MED/34021056
Type: Journal Article/Review
Volume: 8
Parent Publication: Neurology(R) neuroimmunology & neuroinflammation
Issue: 4
ISSN: 2332-7812